Recovery Peptides
TB-500
Research Grade≥99% PurityLyophilized
Synthetic fragment of thymosin beta-4 used in actin-binding and cell migration assays.
Dosage
$45.00
Quantity
Bundle & Save
We accept
Certificate of Analysis
Third Party Tested by Freedom Diagnostics
Frequently Bought Together
Bacteriostatic Water
10 ml
$10.00
GLP-3 RT
10 mg
$110.00
GLP-2 TZ
10 mg
$85.00
NAD+
500 mg
$70.00
GHK-Cu
50 mg
$65.00
BPC-157
5 mg
$45.00
Melanotan II
10 mg
$55.00
Tesamorelin
10 mg
$85.00
MOTS-c
10 mg
$75.00
Research Summary
TB-500
Published research data and clinical observations
🔬
Research Phase
Extensive animal data
💉
Administration
Multiple routes studied
🧬
Key Mechanism
Thymosin Beta-4 fragment
📄
Publications
Peer-reviewed papers
🐁
Subjects Studied
Multiple animal models
What Makes TB-500 Different?
The Science, Simplified
The Body's Repair Signal
TB-500 is the active fragment of Thymosin Beta-4 — a protein found in every nucleated cell. It works by reorganizing the cell's internal skeleton (actin), which controls how cells move to injury sites and build new tissue.
Actin
Primary
G-Actin Sequestration
Cell structural protein
Enables cell migration
Promotes cell proliferation
Drives wound closure
NF-κB
Inhibitor
Inflammatory Pathway
Anti-inflammatory action
Reduces swelling
Prevents excess scarring
Organizes connective tissue
VEGF
Inducer
Angiogenesis
New blood vessel growth
Stem cell mobilization
Hair follicle activation
Cardiac tissue repair
WHY SIZE MATTERS
Travels Anywhere in the Body
Most growth factors only work locally at the injection site. TB-500's small molecular weight lets it travel systemically through tissues:
Promotes cell migration to injury sites regardless of injection location — 61% faster wound closure at day 7 vs controls.
TB-500Systemic (any injection site)
BPC-157Local + some systemic
PRPInjection site only
What Researchers Observed
61%
Faster re-epithelialization at day 7
Malinda et al. (1999) full-thickness wound model
61%
82%
68%
64%
Key Milestones Achieved
85%
42% at day 4, 61% at day 7
78%
Histological assessment
72%
Organized connective tissue vs controls
For context:Philp et al. (2004) demonstrated TB4 promotes angiogenesis, wound healing, and hair follicle development simultaneously. Sosne et al. (2007) confirmed corneal healing via anti-inflammatory NF-kB suppression. Kim & Bhatt (2010) showed enhanced connective tissue organization with reduced myofibroblast appearance.
Compound Information
Technical specifications
❄️ Storage Requirements
Stability Information
Avoid freeze/thaw cyclesProtect from lightKeep refrigerated
Lyophilized (powder)
-20°C · 24+ months
Reconstituted
2-8°C · ~30 days
📋 Development Status
Where It Stands
PreclinicalResearch Use Only
DeveloperRegeneRx Biopharmaceuticals
Trial ProgramMultiple preclinical
Results50+ studies published
This page summarizes published research for informational purposes only. These products are sold exclusively as research chemicals and are not intended for human consumption. Always consult peer-reviewed literature for complete study details.
Your Cart
Your cart is empty